{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:08:05Z","timestamp":1779268085887,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Wuxi Taihu Talent Plan","award":["202101"],"award-info":[{"award-number":["202101"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82304337"],"award-info":[{"award-number":["82304337"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"the China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2023M733899"],"award-info":[{"award-number":["2023M733899"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Jiangsu Funding Program for Excellent Postdoctoral Talent","award":["2023ZB721"],"award-info":[{"award-number":["2023ZB721"]}]},{"name":"the Natural Science Foundation of Jiangsu Province Academy of Traditional Medicine","award":["2024YZRKXJJ21"],"award-info":[{"award-number":["2024YZRKXJJ21"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The formation of foam cells (FCs) is the major contributor to the development of atherosclerosis (AS).\n                      <jats:italic>Gynostemma pentaphyllum<\/jats:italic>\n                      is widely used to treat AS and exhibits biological activity against FCs formation. Narcissoside (Nar) is an important component from\n                      <jats:italic>G. pentaphyllum<\/jats:italic>\n                      flavonoids. This study aimed to reveal the beneficial effect and underlying mechanism of Nar on inhibiting the formation of FCs in AS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The inhibitory effects of Nar on FCs formation were evaluated using Oil Red O staining and flow cytometry in ox-LDL-stimulated THP-1 and BMDMs. High-fat diet (HFD)-induced ApoE\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice were administered Nar for 9\u00a0weeks to assess its therapeutic efficacy in treating AS. Luciferase reporter gene assays, Western blot, and RT-qPCR were performed to investigate the mechanisms of action of Nar, which were further confirmed through in vitro experiments using siRNA of NR4A1 for reverse validation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In vitro, Nar attenuated FCs formation as evidenced by reduced intracellular lipid levels and ox-LDL uptake rates. In vivo, Nar effectively improved lipid profiles and serum inflammatory factors. Histological analysis showed that Nar reduced the area of the necrotic core and lipid accumulation in the aortic roots. Mechanistically, Nar inhibited CD36 transcription by enhancing the expression and nuclear translocation of NR4A1. Mutation of the NR4A1 binding site within the CD36 promoter abolished the inhibitory effect of Nar. Additionally, silencing NR4A1 eliminated Nar\u2019s capacity to suppress ox-LDL uptake and downregulate CD36 expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Nar attenuated AS by inhibiting CD36-mediated FCs formation through upregulating the expression and nuclear translocation of NR4A1, highlighting it as a promising therapeutic candidate for AS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01412-1","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:32:24Z","timestamp":1779265944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Narcissoside attenuates atherosclerosis by suppressing CD36-mediated foam cell formation via upregulation of NR4A1"],"prefix":"10.1186","volume":"21","author":[{"given":"Ziyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiren","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"7855","key":"1412_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524\u201333. https:\/\/doi.org\/10.1038\/s41586-021-03392-8.","journal-title":"Nature"},{"issue":"10","key":"1412_CR2","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","volume":"185","author":"J Bjorkegren","year":"2022","unstructured":"Bjorkegren J, Lusis AJ. Atherosclerosis: recent developments. Cell. 2022;185(10):1630\u201345. https:\/\/doi.org\/10.1016\/j.cell.2022.04.004.","journal-title":"Cell"},{"issue":"5","key":"1412_CR3","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1021\/acs.jmedchem.0c01516","volume":"64","author":"DG Brown","year":"2021","unstructured":"Brown DG, Wobst HJ. A decade of FDA-approved drugs (2010-2019): trends and future directions. J Med Chem. 2021;64(5):2312\u201338. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01516.","journal-title":"J Med Chem"},{"issue":"4","key":"1412_CR4","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1124\/pr.118.017178","volume":"71","author":"D Wang","year":"2019","unstructured":"Wang D, Yang Y, Lei Y, et al. Targeting foam cell formation in atherosclerosis: therapeutic potential of natural products. Pharmacol Rev. 2019;71(4):596\u2013670. https:\/\/doi.org\/10.1124\/pr.118.017178.","journal-title":"Pharmacol Rev"},{"issue":"12","key":"1412_CR5","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.it.2019.10.002","volume":"40","author":"V Guerrini","year":"2019","unstructured":"Guerrini V, Gennaro ML. Foam cells: one size doesn\u2019t fit all. Trends Immunol. 2019;40(12):1163\u201379. https:\/\/doi.org\/10.1016\/j.it.2019.10.002.","journal-title":"Trends Immunol"},{"issue":"1","key":"1412_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/bmb\/ldy006","volume":"126","author":"L Zhao","year":"2018","unstructured":"Zhao L, Varghese Z, Moorhead JF, et al. CD36 and lipid metabolism in the evolution of atherosclerosis. Br Med Bull. 2018;126(1):101\u201312. https:\/\/doi.org\/10.1093\/bmb\/ldy006.","journal-title":"Br Med Bull"},{"issue":"1","key":"1412_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/cvr\/cvaa319","volume":"118","author":"H Shu","year":"2022","unstructured":"Shu H, Peng Y, Hang W, et al. The role of CD36 in cardiovascular disease. Cardiovasc Res. 2022;118(1):115\u201329. https:\/\/doi.org\/10.1093\/cvr\/cvaa319.","journal-title":"Cardiovasc Res"},{"key":"1412_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2023.102285","volume":"81","author":"D Bending","year":"2023","unstructured":"Bending D, Zikherman J. Nr4a nuclear receptors: markers and modulators of antigen receptor signaling. Curr Opin Immunol. 2023;81:102285. https:\/\/doi.org\/10.1016\/j.coi.2023.102285.","journal-title":"Curr Opin Immunol"},{"key":"1412_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.972984","volume":"12","author":"S Deng","year":"2022","unstructured":"Deng S, Chen B, Huo J, et al. Therapeutic potential of NR4a1 in cancer: focus on metabolism. Front Oncol. 2022;12:972984. https:\/\/doi.org\/10.3389\/fonc.2022.972984.","journal-title":"Front Oncol"},{"issue":"6","key":"1412_CR10","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1042\/EBC20210004","volume":"65","author":"SC Lith","year":"2021","unstructured":"Lith SC, de Vries C. Nuclear receptor nur77: its role in chronic inflammatory diseases. Essays Biochem. 2021;65(6):927\u201339. https:\/\/doi.org\/10.1042\/EBC20210004.","journal-title":"Essays Biochem"},{"issue":"44","key":"1412_CR11","doi-asserted-by":"publisher","first-page":"27412","DOI":"10.1073\/pnas.2002997117","volume":"117","author":"PB Yang","year":"2020","unstructured":"Yang PB, Hou PP, Liu FY, et al. Blocking PPAR\u03b3 interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression. Proc Natl Aca Sci USA. 2020;117(44):27412\u201322. https:\/\/doi.org\/10.1073\/pnas.2002997117.","journal-title":"Proc Natl Aca Sci USA"},{"key":"1412_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jff.2018.09.031","volume":"50","author":"C Shen","year":"2018","unstructured":"Shen C, Jiang J, Huang C, Zhu W. Gypenoside LVI attenuates foam cell formation by promoting cholesterol export and inhibiting inflammation response. J Funct Foods. 2018;50:71\u20137. https:\/\/doi.org\/10.1016\/j.jff.2018.09.031.","journal-title":"J Funct Foods"},{"issue":"20","key":"1412_CR13","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.3390\/molecules26206249","volume":"26","author":"C Su","year":"2021","unstructured":"Su C, Li N, Ren R, et al. Progress in the medicinal value, bioactive compounds, and pharmacological activities of Gynostemma pentaphyllum. Molecules. 2021;26(20):6249\u201383. https:\/\/doi.org\/10.3390\/molecules26206249.","journal-title":"Molecules"},{"key":"1412_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2019.103451","volume":"60","author":"C Shen","year":"2019","unstructured":"Shen C, Shi M, Yang H, et al. Inhibitory effects of multi-components from Gynostemma pentaphyllum (Thunb.) Makino on macrophage foam cell formation exhibit multi-target characteristics. J Funct Foods. 2019;60:103451. https:\/\/doi.org\/10.1016\/j.jff.2019.103451.","journal-title":"J Funct Foods"},{"issue":"9","key":"1412_CR15","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.3390\/ijms24098152","volume":"24","author":"M Lee","year":"2023","unstructured":"Lee M, Upadhyay S, Mariyam F, et al. Flavone and hydroxyflavones are ligands that bind the orphan nuclear receptor 4a1 (NR4a1). Int J Mol Sci. 2023;24(9):8152\u201367. https:\/\/doi.org\/10.3390\/ijms24098152.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1412_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11112089","volume":"11","author":"RH Fu","year":"2022","unstructured":"Fu RH, Tsai CW, Liu SP, et al. Neuroprotective capability of narcissoside in 6-OHDA-exposed Parkinson\u2019s disease models through enhancing the MiR200a\/Nrf-2\/GSH axis and mediating MAPK\/Akt associated signaling pathway. Antioxidants. 2022;11(11):2089. https:\/\/doi.org\/10.3390\/antiox11112089.","journal-title":"Antioxidants"},{"key":"1412_CR17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.foodchem.2016.11.063","volume":"221","author":"R Guo","year":"2017","unstructured":"Guo R, Guo X, Li T, Fu X, Liu RH. Comparative assessment of phytochemical profiles, antioxidant and antiproliferative activities of sea buckthorn (Hippopha\u00eb rhamnoides L.) berries. Food Chem. 2017;221:997\u20131003. https:\/\/doi.org\/10.1016\/j.foodchem.2016.11.063.","journal-title":"Food Chem"},{"issue":"Pt A","key":"1412_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120323","volume":"353","author":"R Shuang","year":"2025","unstructured":"Shuang R, Tong Y, Wang X, et al. Narcissoside from Bupleurum chinense DC. alleviates depression by enhancing adult hippocampal neurogenesis via the TREM2\/PI3K\/Akt pathway. J Ethnopharmacol. 2025;353(Pt A):120323. https:\/\/doi.org\/10.1016\/j.jep.2025.120323.","journal-title":"J Ethnopharmacol"},{"key":"1412_CR19","first-page":"1159","volume":"8","author":"M El-Aasr","year":"2016","unstructured":"El-Aasr M, Kabbash A, Abo El-Seoud KA, et al. Antimicrobial and immunomodulatory activities of flavonol glycosides isolated from Atriplex Halimus L. Herb. J Pharm Sci Res. 2016;8:1159\u201368.","journal-title":"J Pharm Sci Res"},{"key":"1412_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/bio.4637","volume":"39","author":"J Cui","year":"2023","unstructured":"Cui J, Fan Y, Lian D, et al. Interaction of narcissoside with \u03b1-amylase from Bacillus subtilis and Porcine pancreatic by multi-spectral analysis and molecular dynamics simulation. Luminescence. 2023;39:e4637. https:\/\/doi.org\/10.1002\/bio.4637.","journal-title":"Luminescence"},{"key":"1412_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2024.110707","volume":"124","author":"E Hoste","year":"2024","unstructured":"Hoste E, Haufroid V, Deldicque L, et al. Atorvastatin-associated myotoxicity: a toxicokinetic review of pharmacogenetic associations to evaluate the feasibility of precision pharmacotherapy. Clin Biochem. 2024;124:110707. https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110707.","journal-title":"Clin Biochem"},{"issue":"2","key":"1412_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021667","volume":"24","author":"S Huo","year":"2023","unstructured":"Huo S, Wang Q, Shi W, et al. ATF3\/SPI1\/SLC31A1 signaling promotes cuproptosis induced by advanced glycosylation end products in diabetic myocardial injury. Int J Mol Sci. 2023;24(2):1667. https:\/\/doi.org\/10.3390\/ijms24021667.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1412_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2174\/1389200222666210114122729","volume":"22","author":"R Balasubramanian","year":"2021","unstructured":"Balasubramanian R, Maideen N. HMG-CoA reductase inhibitors (statins) and their drug interactions involving CYP enzymes, p-glycoprotein and OATP transporters-an overview. Curr Drug Metab. 2021;22(5):328\u201341. https:\/\/doi.org\/10.2174\/1389200222666210114122729.","journal-title":"Curr Drug Metab"},{"issue":"9","key":"1412_CR24","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1080\/17425255.2020.1801634","volume":"16","author":"T Hirota","year":"2020","unstructured":"Hirota T, Fujita Y, Ieiri I. An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins. Expert Opin Drug Metab Toxicol. 2020;16(9):809\u201322. https:\/\/doi.org\/10.1080\/17425255.2020.1801634.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"1412_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/phar.2674","volume":"42","author":"NC Schwier","year":"2022","unstructured":"Schwier NC, Cornelio CK, Boylan PM. A systematic review of the drug-drug interaction between statins and colchicine: patient characteristics, etiologies, and clinical management strategies. Pharmacotherapy. 2022;42(4):320\u201333. https:\/\/doi.org\/10.1002\/phar.2674.","journal-title":"Pharmacotherapy"},{"key":"1412_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176338","volume":"966","author":"A Attiq","year":"2024","unstructured":"Attiq A, Afzal S, Ahmad W, et al. Hegemony of inflammation in atherosclerosis and coronary artery disease. Eur J Pharmacol. 2024;966:176338. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176338.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1412_CR27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148559","volume":"132","author":"AR Tall","year":"2022","unstructured":"Tall AR, Thomas DG, Gonzalez-Cabodevilla AG, et al. Addressing dyslipidemic risk beyond LDL-cholesterol. J Clin Invest. 2022;132(1):e148559. https:\/\/doi.org\/10.1172\/JCI148559.","journal-title":"J Clin Invest"},{"issue":"6","key":"1412_CR28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211314","volume":"219","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhang J, Cui W, et al. CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate. J Exp Med. 2022;219(6):e20211314. https:\/\/doi.org\/10.1084\/jem.20211314.","journal-title":"J Exp Med"},{"issue":"3","key":"1412_CR29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00018-014-1762-5","volume":"72","author":"A Plociennikowska","year":"2015","unstructured":"Plociennikowska A, Hromada-Judycka A, Borzecka K, et al. Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cell Mol Life Sci. 2015;72(3):557\u201381. https:\/\/doi.org\/10.1007\/s00018-014-1762-5.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"1412_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1161\/CIRCRESAHA.123.322910","volume":"134","author":"S Wang","year":"2024","unstructured":"Wang S, Han Y, Liu R, et al. Glycolysis-mediated activation of v-ATPase by nicotinamide mononucleotide ameliorates lipid-induced cardiomyopathy by repressing the CD36-TLR4 axis. Circ Res. 2024;134(5):505\u201325. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.322910.","journal-title":"Circ Res"},{"issue":"12","key":"1412_CR31","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1161\/CIRCRESAHA.119.315833","volume":"125","author":"Y Chen","year":"2019","unstructured":"Chen Y, Yang M, Huang W, et al. Mitochondrial metabolic reprogramming by CD36 signaling drives macrophage inflammatory responses. Circ Res. 2019;125(12):1087\u2013102. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315833.","journal-title":"Circ Res"},{"issue":"3","key":"1412_CR32","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1161\/CIRCRESAHA.111.253377","volume":"110","author":"RN Hanna","year":"2012","unstructured":"Hanna RN, Shaked I, Hubbeling HG, et al. NR4a1 (nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ Res. 2012;110(3):416\u201327. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.253377.","journal-title":"Circ Res"},{"issue":"3","key":"1412_CR33","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1161\/CIRCRESAHA.111.260760","volume":"110","author":"AA Hamers","year":"2012","unstructured":"Hamers AA, Vos M, Rassam F, et al. Bone marrow-specific deficiency of nuclear receptor nur77 enhances atherosclerosis. Circ Res. 2012;110(3):428\u201338. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.260760.","journal-title":"Circ Res"},{"key":"1412_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9363461","volume":"2018","author":"L Zhang","year":"2018","unstructured":"Zhang L, Wang Q, Liu W, et al. The orphan nuclear receptor 4a1: a potential new therapeutic target for metabolic diseases. J Diabetes Res. 2018;2018:9363461. https:\/\/doi.org\/10.1155\/2018\/9363461.","journal-title":"J Diabetes Res"},{"issue":"5","key":"1412_CR35","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1182\/blood.V87.5.2020.2020","volume":"87","author":"HY Huh","year":"1996","unstructured":"Huh HY, Pearce SF, Yesner LM, et al. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood. 1996;87(5):2020\u20138. https:\/\/doi.org\/10.1182\/blood.V87.5.2020.2020.","journal-title":"Blood"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01412-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:32:27Z","timestamp":1779265947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01412-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1412"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01412-1","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}